Evidence map›Paper›PMID 30022632›Full record

ArticleJournal of gynecologic oncology2018

The influence of surgeon volume on outcomes after pelvic exenteration for a gynecologic cancer.

Randa J Jalloul, Alpa M Nick, Mark F Munsell, Shannon N Westin, Pedro T Ramirez, Michael Frumovitz, Pamela T Soliman

Open access · diamondAbstract read
In one paragraph

Article in Journal of gynecologic oncology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
1.2field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 16 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 1 country.

Randa J JalloulDepartment of Obstetrics and Gynecology, McGovern Medical School at The University of Texas Health Science Center at Houston (UTHealth), Houston, TX, USA.ORCID https://orcid.org/0000-0002-2727-0735
Alpa M NickSaint Thomas Medical Partners-Gynecologic Oncology and University of Tennessee Health Sciences Center, Nashville, TN, USA.ORCID https://orcid.org/0000-0001-9232-1458
Mark F MunsellDepartment of Biostatistics, University of Texas, MD Anderson Cancer Center, Houston, TX, USA.ORCID https://orcid.org/0000-0001-9654-4958
Shannon N WestinDepartment of Gynecologic Oncology and Reproductive Medicine, University of Texas, MD Anderson Cancer Center, Houston, TX, USA.ORCID https://orcid.org/0000-0002-1922-0156
Pedro T RamirezDepartment of Gynecologic Oncology and Reproductive Medicine, University of Texas, MD Anderson Cancer Center, Houston, TX, USA.ORCID https://orcid.org/0000-0003-4198-9575
Michael FrumovitzDepartment of Gynecologic Oncology and Reproductive Medicine, University of Texas, MD Anderson Cancer Center, Houston, TX, USA.ORCID https://orcid.org/0000-0002-0810-2648
Pamela T SolimanDepartment of Gynecologic Oncology and Reproductive Medicine, University of Texas, MD Anderson Cancer Center, Houston, TX, USA. psoliman@mdanderson.org.ORCID https://orcid.org/0000-0002-8784-9212
The University of Texas MD Anderson Cancer Center · USSaint Thomas Health · USThe University of Texas Health Science Center · US

Funding

Tumor Evolution and Metastasis ProgramP30CA016672 · NCI · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI Scott Kopetz · 1985 to 2026
$290.8M
Paul Calabresi Clinical Oncology AwardK12CA088084 · NCI · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI David S. Hong, Scott Kopetz · 2000 to 2026
$14.0M
NCI NIH HHS K12 CA088084NCI NIH HHS P30 CA016672
6 · The paper itself

Abstract

objectiveTo determine the effect of surgeon experience on intraoperative, postoperative and long-term outcomes among patients undergoing pelvic exenteration for gynecologic cancer.

methodsThis was a retrospective analysis of all women who underwent exenteration for a gynecologic malignancy at MD Anderson Cancer Center, between January 1993 and June 2013. A logistic regression was used to model the relationship between surgeon experience (measured as the number of exenteration cases performed by the surgeon prior to a given exenteration) and operative outcomes and postoperative complications. Cox proportional hazards regression was used to model survival outcomes.

resultsA total of 167 exenterations were performed by 19 surgeons for cervix (78, 46.7%), vaginal (43, 25.8%), uterine (24, 14.4%), vulvar (14, 8.4%) and other cancer (8, 4.7%). The most common procedure was total pelvic exenteration (69.4%), incontinent urinary diversion (63.5%) and vertical rectus abdominis musculocutaneous reconstruction (42.5%). Surgical experience was associated with decreased estimated blood loss (p<0.001), intraoperative transfusion (p=0.009) and a shorter length of stay (p=0.03). No difference was noted in the postoperative complication rate (p=0.12-0.95). More surgeon experience was not associated with overall or disease specific survival: OS (hazard ratio [HR]=1.02; 95% confidence interval [CI]=0.97-1.06; p=0.46) and DSS (HR=1.01; 95% CI=0.97-1.04; p=0.66), respectively.

conclusionPatients undergoing exenteration by more experienced surgeons had improvement in intraoperative factors such as estimated blood loss, transfusion rates and length of stay. No difference was seen in postoperative complication rates, overall or disease specific survival.

Indexed as

Clinical CompetenceAdultAgedAged, 80 and overBlood Loss, SurgicalBlood TransfusionFemaleFollow-Up StudiesGenital Neoplasms, FemaleHumansLength of StayMiddle AgedPelvic ExenterationPostoperative ComplicationsTexasTreatment OutcomeGynecologic NeoplasmsPelvic ExenterationPregnancy OutcomesSurgeon Volume

Identifiers

PMID30022632
PMCPMC6078889
OpenAlexW2801813688

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.